Form 4: Roivant Sciences CFO Richard Pulik Reports Share Transaction

Roivant Sciences CFO Richard Pulik disposed of 2,341 common shares to cover tax obligations related to vested RSUs.

Summary

• Richard Pulik, the CFO of Roivant Sciences Ltd., reported a transaction involving the company's common shares.
• On November 28, 2024, Mr. Pulik disposed of 2,341 common shares.
• The shares were disposed of at a price of $12.69 per share.
• This transaction was a 'net settlement' by Roivant to cover tax withholding obligations related to the vesting of previously granted Restricted Stock Units (RSUs).
• Following the transaction, Mr. Pulik directly owns 276,601 common shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is neither positive nor negative for the company's overall outlook. It is a neutral event.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• The transaction is a standard practice for executives receiving equity compensation, where a portion of shares are sold to cover tax liabilities.
• Many companies use similar net settlement methods for RSU vesting to simplify tax obligations for employees.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard procedure for executive compensation.

Key Dates

Keywords

Roivant Sciences, Richard Pulik, CFO, share transaction, Form 4, RSU, net settlement, tax withholding